叙述性评论
医学
叙述的
内科学
重症监护医学
艺术
文学类
作者
Miguel Mansilla‐Polo,D. Morgado‐Carrasco
标识
DOI:10.1007/s13555-024-01203-2
摘要
The risk of infections associated with biological drugs (BD) and Janus kinase inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth of studies that evaluate both pharmacological groups together and, furthermore, compare them. Here, we review the risk of infections associated with BD and JAKi used in dermatology.
科研通智能强力驱动
Strongly Powered by AbleSci AI